JAZZ PHA reported $119.19M in Cost of Sales for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Abbvie ABBV:US $ 4499M 307M
Aerie Pharmaceuticals AERI:US $ 6.18M 0.52M
ALKERMES ALKS:US 49.56M 3.56M
Amarin AMRN:US $ 32.16M 3.83M
Antares Pharma ATRS:US $ 16.44M 0M
Biodelivery Sciences International BDSI:US $ 4.28M 1.54M
Coherus Biosciences CHRS:US $ 16.7M 9.18M
Eli Lilly And LLY:US $ 1430.8M 522.4M
Emergent Biosolutions EBS:US $ 227.8M 128.5M
Endo International Ordinary Shares ENDP:US $ 313.43M 23.44M
Flexion Therapeutics FLXN:US $ 4.98M 1.11M
Halozyme Therapeutics HALO:US $ 23.02M 4.8M
Heron Therapeutics HRTX:US $ 14.52M 5.32M
Hikma Pharmaceutical HIK:LN 600M 2M
Horizon Pharma HZNP:US $ 201M 100.63M
IONIS PHARMACEUT IONS:US $ 2.96M 0.38M
Lannett LCI:US $ 83.35M 2.56M
Mckesson MCK:US $ 59486M 3641M
Merk MRK:US $ 3042M 413M
Nektar Therapeutics NKTR:US $ 7.67M 1.91M
Pacira Pharmaceuticals PCRX:US $ 35.25M 3.9M
Perrigo Ordinary Shares PRGO:US $ 632.1M 9.5M
Pfizer PFE:US $ 6992M 2820M
Phibro Animal Health PAHC:US $ 150.45M 7.89M
Revance Therapeutics RVNC:US $ 5.43M 1.21M
Supernus Pharmaceuticals SUPN:US $ 25.03M 10.07M
Teva Pharmaceutical Industries TEVA:US $ 1989M 2M
Xeris Pharmaceuticals Inc XERS:US $ 3.38M 1.56M
Zoetis ZTS:US $ 564M 21M